Vimarsana
Biggest News Aggregation in the World

Page 6 - Valuating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valuating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valuating Today - Breaking & Trending Today

India evaluating American, French engine offers for indigenous aircraft projects - Vimarsana News

India evaluating American, French engine offers for indigenous aircraft projects

In a significant step towards indigenising critical warfighting equipment, India is evaluating proposals from American and French firms for its Made in India aircraft including the LCA Mark 2 and the Advanced Medium Combat Aircraft.

NRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

NRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

Enrollment continues in the Phase 2b/3 clinical trial evaluating NRX-101 in Suicidal Treatment-Resistant Bipolar Depression; data expected in 4Q 2023National educational campaign launched to further... | May 16, 2023

Neurocrine Biosciences Presents INGREZZA Capsules Data on Long-Term Improvements and Psychiatric Stability in Patients with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder at the Schizophrenia International Research Society - Vimarsana News

Neurocrine Biosciences Presents INGREZZA Capsules Data on Long-Term Improvements and Psychiatric Stability in Patients with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder at the Schizophrenia International Research Society

SAN DIEGO - Neurocrine Biosciences, Inc. today announced findings from a post hoc analysis of two long-term studies of INGREZZA capsules evaluating global tardive dyskinesia improvement and... | May 16, 2023

Neurocrine Biosciences Presents INGREZZA® (valbenazine) Capsules Data on Long-Term Improvements and Psychiatric Stability in Patients With Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder at the Schizophrenia International Research Society 2023 Annual Congress - Vimarsana News

Neurocrine Biosciences Presents INGREZZA® (valbenazine) Capsules Data on Long-Term Improvements and Psychiatric Stability in Patients With Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder at the Schizophrenia International Research Society 2023 Annual Congress

SAN DIEGO, May 15, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. today announced findings from a post hoc analysis of two long-term studies of INGREZZA® capsules evaluating global tardive... | May 15, 2023

Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results - Vimarsana News

Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

Company on track to complete enrollment in ongoing pivotal Phase 3 global study evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 by year end 2023 ... | May 15, 2023